Research Grants

Grant Funding for Pharmacist-Led Cancer Research

HOPA research grants provide support for projects that are likely to result in facilitating the efforts of hematology/oncology pharmacists to optimize the care of individuals affected by cancer. Projects should align closely with the HOPA strategic imperative to support pharmacist-led research that advances patient care and the profession itself.

HOPA Research Fund Award

Applications are currently closed.

The Research Fund Award (RFA) is intended to support a hematology/oncology pharmacy practice research project. Pharmacy practice is broadly defined to include areas of research such as: clinical or patient outcomes, surveys, patient safety, standards validation/benchmarking, and basic/translational science applications.

Multiple institutions may be involved in the project, and projects with co-principal investigators are allowed. The PI of the proposal must be an active HOPA member.

A subsequent publication resulting from the research project is expected within a year of the study completion. In addition, the awardee is expected to present the results of their research at the HOPA Annual Meeting. The presentation is expected to occur no later than two years after the release of the research funds, as annual conference presentation slots allow.

A total of $100,000 is available to be awarded to up to three grants through a competitive peer-review process. HOPA aims to fund at least one practice-based/clinical and one basic/translational study each year. Applications are now closed.

Contact the HOPA Education team with questions

Early Career Research Grant

Applications are currently closed.

The Early Career Research Grant (ECRG) provides funding to promising investigators early in your career to encourage and promote quality, basic, and pre-clinical translational lab-based research. You are also encouraged to pursue clinical or patient-focused research in hematology/oncology pharmacy.

The purpose of this award is to fund US-based pharmacists within their first 7 years post completion of formal training and have not yet attained R21 (NIH Exploratory/Developmental Research Grant Award) level funding.

Awarded early career pharmacists will be required to work with a mentor either from their sponsoring institution or to find a mentor from another institution within the United States. The PI of the proposal must also be an active HOPA member.

The Early Career Research Grant will award up to $50,000 to one or two chosen applicants through a competitive peer-review process.

Each year HOPA's call for proposals open in the fall and grants are awarded the following spring. Applications are now closed.

Contact the HOPA Education team with questions